Insulet Corporation (PODD)FMR LLC cut its PODD stake below 5% (1.4%) 1.4%

1.4%

Stake · was 5.6%

964K

Shares owned

Stake as of

Jun 30, 2026

Filed

Aug 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 29, 2026CongressDisclosed partial sale of PODD — reported range $100,001 - $250,000
2. May 6, 2026Company filing · Form 8-K · ResultsReported its results
3. May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.6%
4. May 7, 2026CongressDisclosed sale of PODD — reported range $100,001 - $250,000
5. May 14, 20265% stakeCapital Research Global Investors reported a passive stake (13G) of 2.4%
6. May 20, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
7. May 20, 2026FDARecall: Omnipod 5 Pods. Includes the below Model/REF Numbers: 1. POD-OMNI-I1-6720. 2. POD-OMNI-I1-6220. 3. OMNI-I1-6729 (10-Pack), OMNI-I1-6720 (Single Pod). 4. OMNI-I…
8. May 20, 2026FDARecall: Omnipod DASH Pod. Includes the below Model/REF Numbers: 1. POD-BLE-I1-525 (5-Pack), POD-BLE-I1-520 (Single Pod). 2. POD-BLE-I1-529 (10-Pack), POD-BLE-I1-520 (S…
9. May 20, 2026FDARecall: Omnipod (Eros) Pod. Includes the below Model/REF Numbers: 1. POD-ZXP425 (10 Pack), POD- ZXP420 (Single Pod). 2. ZXR425 (10-Pack), ZXR420 (Single Pod). 3. ZXP42…
10. Jun 3, 2026Insider · 3 peopleInsiders: 2 purchases (~$898K), 1 sale (~$60K)
11. Jun 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 24, 2026, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Jonathan J. Mazelsky as a Class II director, effective July 1, 2026.”
12. Jun 29, 2026FDAFDA device clearance: Omnipod 6 algorithm

What came next

1. Jul 2, 2026Court · District Court, D. MassachusettsSecurities lawsuit filed: In re Insulet Corporation Securities Litigation
2. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
3. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 1.4%
4. Aug 18, 2026CongressDisclosed purchase of PODD — reported range $1,001 - $15,000
5. Sep 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 3, 2026, Timothy J. Scannell, a member of the Board of Directors (the "Board") of Insulet Corporation (the "Company"), notified the Company of his decision to step down from the Board for health reasons, effective September 3, 2026.”
6. Sep 14, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 14, 2026, the Talent and Compensation Committee (the "Committee") of the Board of Directors (the "Board") of Insulet Corporation (the "Company") approved and adopted the Insulet Nonqualified Deferred Compensation Plan (the "Plan"), with such Plan to be effective on January 1, 2027.”
7. Sep 21, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Insulet Corporation

For Insulet Corporation, OQRO holds 1 Congress trade report and 12 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PODD page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Insulet Corporation

• House Clerk periodic transaction reportSep 10, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its PODD page.